egnite Health’s Post

View organization page for egnite Health, graphic

28,241 followers

We're excited to see new medical therapy options 💊 for hypertrophic cardiomyopathy with class 1 recommendations in the newly released 2024 guidelines for management. https://ow.ly/4L7050RGmT4 #Cardiology

Caroline Girardeau, PharmD, MBA, PMP, BCPS

Experienced PharmD and Clinical Research Associate Working to Drive Value and Innovation in Healthcare and Life Sciences

1mo

I enjoyed reading about the new addition of myosin inhibitors in patients with obstructive hypertrophic cardiomyopathy (HCM) who do not derive adequate symptom relief from 1st line drug therapy. Thank you for sharing this publication!

To view or add a comment, sign in

Explore topics